CD14 and myeloid sarcoma: RT-qPCR was also used to measure TAAR1 levels in CD14+ monocytes from a different cohort of MS patients and healthy volunteers (Figure 1B) with a significant decrease in relative TAAR1 expression seen in MS patients (* p = 0.0424, t = 2.194, df = 17).